Clinical Trial Update: Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the safety, tolerability, and preliminary efficacy of ST266 in infants with necrotizing entero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• ST266

Snippet

Sponsor: Noveome Biotherapeutics, formerly Stemnion | Conditions: Necrotizing Enterocolitis | Phase 1, Phase 2 | Status: RECRUITING